Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial. (Q54286282)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23096218

Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial. (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23096218

7

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23096218

George Fountzilas

16

object named as

G Fountzilas

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23096218

author name string

K Pliarchopoulou

1

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23096218

K T Kalogeras

2

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23096218

R Kronenwett

3

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23096218

R M Wirtz

4

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23096218

A G Eleftheraki

5

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23096218

A Batistatou

6

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23096218

N Soupos

8

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23096218

G Polychronidou

9

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23096218

H Gogas

10

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23096218

E Samantas

11

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23096218

C Christodoulou

12

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23096218

T Makatsoris

13

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23096218

N Pavlidis

14

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23096218

D Pectasides

15

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23096218

publication date

25 October 2012

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23096218

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23096218

71

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23096218

1

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23096218

245-255

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23096218

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2002-Z

21 January 2018

Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2002-Z

21 January 2018

Molecular classification and molecular forecasting of breast cancer: ready for clinical application?

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2002-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2002-Z

21 January 2018

MgcRacGAP controls the assembly of the contractile ring and the initiation of cytokinesis

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2002-Z

21 January 2018

Rho family proteins in cell adhesion and cell migration.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2002-Z

21 January 2018

Role of Rho GTPases in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2002-Z

21 January 2018

Rho GTPases as key transducers of proliferative signals in g1 cell cycle regulation

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2002-Z

21 January 2018

Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2002-Z

21 January 2018

Cytoskeletal integrity is required throughout the mitogen stimulation phase of the cell cycle and mediates the anchorage-dependent expression of cyclin D1

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2002-Z

21 January 2018

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2002-Z

21 January 2018

Recent advances in systemic therapy: new diagnostics and biological predictors of outcome in early breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2002-Z

21 January 2018

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2002-Z

21 January 2018

Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2002-Z

21 January 2018

Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III tri

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2002-Z

21 January 2018

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2002-Z

21 January 2018

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2002-Z

21 January 2018

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2002-Z

21 January 2018

Alteration of topoisomerase II-alpha gene in human breast cancer: association with responsiveness to anthracycline-based chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2002-Z

21 January 2018

Polysomy 17 in breast cancer: clinicopathologic significance and impact on HER-2 testing.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2002-Z

21 January 2018

Prognostic utility of β-tubulin isotype III and correlations with other molecular and clinicopathological variables in patients with early breast cancer: a translational Hellenic Cooperative Oncology Group (HeCOG) study.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2002-Z

21 January 2018

RNA extraction from archival formalin-fixed paraffin-embedded tissue: a comparison of manual, semiautomated, and fully automated purification methods

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2002-Z

21 January 2018

Quantitative determination of estrogen receptor, progesterone receptor, and HER2 mRNA in formalin-fixed paraffin-embedded tissue--a new option for predictive biomarker assessment in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2002-Z

21 January 2018

REporting recommendations for tumor MARKer prognostic studies (REMARK).

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2002-Z

21 January 2018

Use of archived specimens in evaluation of prognostic and predictive biomarkers

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2002-Z

21 January 2018

Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2002-Z

21 January 2018

Oncogenic Ras downregulates Rac activity, which leads to increased Rho activity and epithelial-mesenchymal transition

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2002-Z

21 January 2018

Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/Cip1.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2002-Z

21 January 2018

Rho-regulatory proteins in breast cancer cell motility and invasion

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2002-Z

21 January 2018

Identifiers

10.1007/S00280-012-2002-Z

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23096218

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23096218

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54286282&oldid=2212410054"